申请人:Boehringer Mannheim GmbH
公开号:US04086347A1
公开(公告)日:1978-04-25
9-[3-(4-Phenoxymethylpiperidino)-propyl]-adenines of the formula ##STR1## wherein R.sub.1 is a hydrogen atom or a lower alkyl radical, R.sub.2 is a hydrogen atom, a ower alkyl radical optionally substituted by hydroxyl, or a cycloalkyl radical, or R.sub.1 and R.sub.2 together with the nitrogen atom to which they are attached form a heterocyclic ring, and R.sub.3 is a hydrogen atom, a halogen atom, a lower alkyl radical or a lower alkoxy radical, In the form of the free base or a salt thereof, exhibit anti-allergic, anti-inflammatory, anti-oedematous and anti-hypertensive activity.
该文段描述的是公式为##STR1##的9-[3-(4-Phenoxymethylpiperidino)-propyl]-腺嘌呤,其中R.sub.1为氢原子或低级烷基基团,R.sub.2为氢原子、可选地被羟基取代的低级烷基基团或环烷基基团,或者R.sub.1和R.sub.2与它们连接的氮原子形成杂环环,R.sub.3为氢原子、卤原子、低级烷基或低级烷氧基基团。该化合物以游离碱或其盐的形式,具有抗过敏、抗炎、抗水肿和降压活性。